• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2022 Apr 7;e0224021.
doi: 10.1128/spectrum.02240-21. Online ahead of print.
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico


Selene Zárate[SUP] #[/SUP][SUP] 1 [/SUP], Blanca Taboada[SUP] #[/SUP][SUP] 2 [/SUP], José Esteban Muñoz-Medina[SUP] 3 [/SUP], Pavel Iša[SUP] 2 [/SUP], Alejandro Sanchez-Flores[SUP] 4 [/SUP], Celia Boukadida[SUP] 5 [/SUP], Alfredo Herrera-Estrella[SUP] 6 [/SUP], Nelly Selem Mojica[SUP] 7 [/SUP], Mauricio Rosales-Rivera[SUP] 8 [/SUP], Bruno Gómez-Gil[SUP] 9 [/SUP], Angel Gustavo Salas-Lais[SUP] 10 [/SUP], Clara Esperanza Santacruz-Tinoco[SUP] 11 [/SUP], Héctor Montoya-Fuentes[SUP] 12 [/SUP], Julio Elias Alvarado-Yaah[SUP] 10 [/SUP], Gloria María Molina-Salinas[SUP] 13 [/SUP], Gloria Elena Espinoza-Ayala[SUP] 14 [/SUP], José Antonio Enciso-Moreno[SUP] 15 [/SUP], Rosa María Gutiérrez-Ríos[SUP] 16 [/SUP], Antonio Loza[SUP] 2 [/SUP], Joaquín Moreno-Contreras[SUP] 2 [/SUP], Rodrigo García-López[SUP] 2 [/SUP], Xaira Rivera-Gutierrez[SUP] 2 [/SUP], Andreu Comas-García[SUP] 17 [/SUP], Rosa María Wong-Chew[SUP] 18 [/SUP], Maria-Eugenia Jiménez-Corona[SUP] 19 [/SUP], Rosa María Del Angel[SUP] 20 [/SUP], Joel Armando Vazquez-Perez[SUP] 21 [/SUP], Margarita Matías-Florentino[SUP] 5 [/SUP], Marissa Pérez-García[SUP] 5 [/SUP], Santiago Ávila-Ríos[SUP] 5 [/SUP], Hugo G Castelán-Sánchez[SUP] 22 [/SUP], Luis Delaye[SUP] 23 [/SUP], León P Martínez-Castilla[SUP] 22 24 [/SUP], Marina Escalera-Zamudio[SUP] 25 [/SUP], Susana López[SUP] 2 [/SUP], Carlos F Arias[SUP] #[/SUP][SUP] 2 [/SUP]



Affiliations

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, the emergence and rapid increase of the B.1.1.7 (Alpha) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in the United Kingdom in September 2020, was well documented in different areas of the world and became a global public health concern because of its increased transmissibility. The B.1.1.7 lineage was first detected in Mexico during December 2020, showing a slow progressive increase in its circulation frequency, which reached its maximum in May 2021 but never became predominant. In this work, we analyzed the patterns of diversity and distribution of this lineage in Mexico using phylogenetic and haplotype network analyses. Despite the reported increase in transmissibility of the B.1.1.7 lineage, in most Mexican states, it did not displace cocirculating lineages, such as B.1.1.519, which dominated the country from February to May 2021. Our results show that the states with the highest prevalence of B.1.1.7 were those at the Mexico-U.S. border. An apparent pattern of dispersion of this lineage from the northern states of Mexico toward the center or the southeast was observed in the largest transmission chains, indicating possible independent introduction events from the United States. However, other entry points cannot be excluded, as shown by multiple introduction events. Local transmission led to a few successful haplotypes with a localized distribution and specific mutations indicating sustained community transmission. IMPORTANCE The emergence and rapid increase of the B.1.1.7 (Alpha) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world were due to its increased transmissibility. However, it did not displace cocirculating lineages in most of Mexico, particularly B.1.1.519, which dominated the country from February to May 2021. In this work, we analyzed the distribution of B.1.1.7 in Mexico using phylogenetic and haplotype network analyses. Our results show that the states with the highest prevalence of B.1.1.7 (around 30%) were those at the Mexico-U.S. border, which also exhibited the highest lineage diversity, indicating possible introduction events from the United States. Also, several haplotypes were identified with a localized distribution and specific mutations, indicating that sustained community transmission occurred in the country.

Keywords: Alpha; Mexico; SARS-CoV-2; genomic surveillance.
 
Back
Top Bottom